Background and Purpose-Elevated blood pressure (BP) is commonly observed in acute ischemic stroke and is known to be associated with hemorrhagic transformation (HT). However, the effect of BP variability on the development of HT is not known well. Methods-A consecutive series of patients with acute ischemic stroke, who were hospitalized within 24 hours of onset and showed no HT on initial gradient echo MRI, were enrolled in this study. BP measurements during the first 72 hours were obtained, and BP variability of each patient was described using various summary parameters: SD, maximum (max), minimum (min), difference between max and min (maxϪmin), average squared difference between successive measurements (sv), and maximum sv (svmax). Results-Of 792 patients meeting the eligibility criteria, 70 (8.8%) developed HT. Among BP variability parameters categorized into quartiles, SBP max , SBP min , SBP maxϪmin , SBP svmax , DBP SD , DBP max , DBP min , DBP maxϪmin , and DBP svmax were significantly associated with HT independent of mean SBP, age, interval from onset to arrival, initial stroke severity, diabetes mellitus, stroke subtype, thrombolysis, initial glucose, and total cholesterol (PϽ0.05 on likelihood ratio test of trend). The analyses about the interaction between thrombolysis and variability parameters showed that the effects of BP variability on the development of HT did not differ by whether patients received thrombolysis or not. Conclusions-Our study suggests that we may consider not only the absolute level of BP but also its variability to prevent hemorrhagic transformation. (Stroke. 2010;41:2512-2518.)
H emorrhagic transformation (HT) is a prevalent and perhaps the most critical complication related to the management of acute ischemic stroke. 1 Rates of HT from 10% to 30% have been reported among patients treated with recombinant tissue plasminogen activator (rt-PA). 2, 3 There is a concern that thrombolysis-related HT might dramatically worsen the prognosis of a patient. 4 It has been clearly shown that the increase of hematoma size is accompanied by the significant increase in the risk of deterioration during the first 24 hours and the 3-month case-fatality. 5 The extent of cerebral infarction on baseline CT scan, congestive heart failure, old age, and high baseline systolic blood pressure (BP) were reported to be associated with HT in patients treated with rt-PA. 1, 6 Among these factors, the role of high baseline systolic BP is notable in both experimental and clinical settings. 7, 8 The current American Heart Association/American Stroke Association guidelines for the early management of acute ischemic stroke recommend to maintain systolic BP (SBP) below 185 mm Hg and diastolic BP (DBP) below 110 mm Hg before beginning intravenous thrombolytic therapy. 9 HT is commonly observed even when revascularization therapy is not given. 10, 11 Despite the belief in the association between BP and HT, there is still uncertainty in their causal relationship. Numerous studies about the role of BP repeatedly told us that high level of BP in acute stroke is associated with a poor outcome. 12 However, with respect to BP variability, its impact on clinical outcome has been raised quite recently. [13] [14] [15] BP variability may have an negative influence on cerebral perfusion and aggravate an ischemic injury where autoregu-lation has been already impaired because of the injury itself. 14 A sudden rise of BP can contribute to the rupture of blood vessels damaged and weakened by the ischemic insult. It is therefore reasonable to hypothesize that BP variability contributes to the development of HT.
In the present study, we intended to investigate whether BP variability increases the risk of HT after acute ischemic stroke and, if it does, the extent of the relationships between HT and BP variability parameters.
Methods
A consecutive series of patients with ischemic stroke, who were admitted to Seoul National University Bundang Hospital between January 1, 2004 and August 31, 2007, were identified using the Korean stroke registry database. 16 We enrolled patients hospitalized within 24 hours of stroke onset and showing relevant lesions on an initial diffusion-weighted MRI (DWI). Those who did not undergo gradient echo T2-weighted MRI (GRE), showed HT on an initial GRE, had no follow-up brain image within the first 14 days of hospitalization, or had inadequate BP data were excluded. The study protocol was approved by the local institutional review board. The casual supine BP was measured from a nonhemiparetic arm using a standard mercury sphygmomanometer and entered manually into the electronic medical record (EMR) system as part of the clinical routine when patients were cared for on general wards. In the emergency room, stroke unit, or intensive care unit, BP was measured using a noninvasive BP monitoring system and recorded automatically into the EMR system. BP measurements within the first 72 hours were thus obtained from the EMR system electronically.
Demographics, clinical profiles that included the TOAST (Trial of Org 10 172 in Acute Stroke Treatment) classification of stroke subtype, 17 treatments, and laboratory findings were obtained directly from the stroke registry or by reviewing medical records. Two neurologists (Y.K. and J.H.P.) reviewed all brain images (CT or MRI) taken within the first 14 days and determined the neuroimaging profile of each patient with regard to the presence and severity of HT (weighted ϭ0.89; 95% confidence interval [CI], 0.82 to 0.96), the grade of white matter changes 18 (0.59; 0.51 to 0.68), and the presence and number of microbleeds 19 (0.74, 0.64 to 0.83). According to the criteria proposed by the European Cooperative Acute Stroke Study (ECASS) group, 20 HT was classified into four categories based on radiological distinctions: (1) hemorrhagic infarction type 1 (HI-1); (2) hemorrhagic infarction type 2 (HI-2); (3) parenchymal hematoma type 1 (PH-1); and (4) parenchymal hematoma type 2 (PH-2).
The BP profile during the first 72 hours was described using various parameters for each of SBP and DBP: average (mean), maximum (max), minimum (min), difference between max and min (maxϪmin), SD. In addition, we used successive variation (sv) and maximum sv (svmax) to represent BP variability. 14 sv is the square root of average difference in BP between successive measurements, which is calculated by the following equation:
where n is a total count of BP measurement. svmax is the maximal value of squared differences between successive BP measurements. Although SD is a widely used measure of variation, sv and svmax can represent time sequence of variation. 14 We thus had 6 parameters representing the BP variability for each of SBP and DBP: max, min, maxϪmin, SD, sv, and svmax.
Depending on the type of variables, the baseline characteristics of patients are presented as number (%), meansϮSD, or median (interquartile range [IQR] ). Comparisons between HT and no-HT groups were made by Student t test or Mann-Whitney U-test as appropriate. The appropriateness of test was determined by visual inspection of the normality on the distribution of each continuous variable using histogram. Proportions were compared using Pearson's 2 test. Multiple logistic regression analysis was performed to assess the independent association of each BP parameter with the development of HT. Variables for adjustments were identified from univariate analyses when their probability values were Ͻ0.25. Mean SBP was chosen to represent the level of BP during the first 72 hours and was also included in multiple logistic regression models. Because BP parameters were mostly different from each other in the meaning of one unit change, they were categorized into quartiles. To avoid the risk of multicollinearity caused by including highly correlated variables in the same model, we replaced each variability parameter one by one instead of including all the BP variability parameters in one model. Resulting adjusted odds ratios (ORs) and 95% CIs are reported. Dose-response relationships between variability parameters and the development of HT were examined using a likelihood ratio test of trend.
In line with methods used elsewhere, 13, 21 we examined the consistency of BP variability in its impact on HT by different BP levels. Patients were stratified according to the quartile of their mean BP during the first 72 hours, and each stratum were further divided into low variability (Յmedian) and high variability (Ͼmedian) groups using the median value of BP variability parameters of the stratum. The proportion of patients who developed HT was calculated in each group. The homogeneity in the association of BP variability parameters and HT across the mean BP quartiles was determined using the Breslow and Day's test.
All analyses were carried out using SPSS for Windows version 15.0 (SPSS Inc, Chicago, Ill), and a probability value of Ͻ0.05 was considered as statistically significant.
Results
Among 1763 patients who were hospitalized for acute ischemic stroke during the study, 1046 (59.3%) were admitted within 24 hours of symptom onset. DWIs were performed in almost all patients (99.2%, 1038/1046), and 1025 had relevant lesions on initial DWI. From these 1025, a number of patients were excluded because of the following causes: 130 (12.7%) who did not undergo GRE, 23 (2.2%) who showed HT on an initial GRE, 71 (6.9%) who had no follow-up images, and 9 (1.1%) who had inadequate BP (Ͻ9 BP measurements during the first 72 hours). As a result, 792 patients were finally enrolled in this study. Median delay between stroke onset and the last follow-up images was 4 days (IQR, 2 to 6 days).
Follow-up images revealed HT in 8.8% (70/792); the median interval from symptom onset to the detection of HT was 1 day (IQR, 0 to 4 days). CT was the only follow-up imaging modality in 112 (14.1%). MRI was repeated in the remaining 680 patients (85.9%). The frequency of HT was 12.5% in the CT-only group and 8.2% in the MRI group (Pϭ0.14 with Pearson's 2 test). Among the 70 patients with HT, 17% (12/70) were symptomatic and types of HT were as follows: HI-1 in 6 patients (8.6%); HI-2 in 16 (22.9%); PH-1 in 27 (38.6%); and PH-2 in 15 (21.4%). Clinical characteristics are presented according to the presence of HT (Table 1) . Compared to patients without HT, patients with HT were more likely to have large artery atherosclerosis or cardioembolic stroke, to receive thrombolysis, to arrive at the hospital quickly, to have severe neurological deficits, and to show a high serum glucose level.
The median frequency of BP measurements per person during the first 72 hours was 18 times (IQR, 14 to 57). The HT and no-HT groups were different in the frequency of BP measurements (PϽ0.001 on the Mann-Whitney U test) (Table 1 ) but were not in the average of either SBP or DBP (SBP mean and DBP mean ) ( Table 2 ). The SDs and maximum values (SBP SD , SBP max , DBP SD , and DBP max ) were higher in the HT group than the no-HT group, but the minimum values (SBP min and DBP min ) were lower in the HT group (PϽ0.001). Consequently, the differences between the maximum and minimum (SBP maxϪmin and DBP maxϪmin ) were higher in the HT group than the no-HT group (PϽ0.001). The successive variation for SBP (SBP sv ) did not differ by the presence of HT (Pϭ0.37), but the successive variation for DBP (DBP sv ) did (12.9Ϯ4.5 in the HT group and 11.4Ϯ3.5 in the no-HT group, Pϭ0.002). The maximum successive variation (SBP svmax and DBP svmax ) was higher in the HT group than the no-HT group (PϽ0.001).
Cutoff values of quartiles for BP variability parameters and the rate of HT in each quartile were shown in Table 3 . Using a Mantel-Haenszel 2 test, significant linear associations were noted in the rate of HT with quartiles except SBP mean , SBP SD , SBP sv , and DBP mean . Simple comparisons between the HT and no-HT groups yielded PϽ0.25 for age, interval from symptom onset to arrival, National Institute of Health Stroke Scale (NIHSS), diabetes mellitus, TOAST (Trial of Org 10 172 in Acute Stroke Treatment) classification, thrombolysis, serum glucose, and total cholesterol (Table 1) . With adjustments for these variables and mean SBP during the first 72 hours, the ORs and 95% CIs were calculated for each quartile of BP variability parameters. SBP max , SBP min , SBP maxϪmin , SBP svmax , DBP SD , DBP max , DBP min , DBP maxϪmin , and DBP svmax , showed a significant association with the development of HT (Table 4 ). To determine whether the effect of BP variability on the risk of HT differs according to thrombolysis, interaction terms between BP variability parameters and thrombolysis were added to logistic models presented in Table 4 . There was no significant interaction except SBP sv (see the Supplemental Table, available at http://stroke.ahajournals.org). Furthermore, as a sensitivity analysis, we included mean DBP instead of mean SBP in multivariable logistic regression models, but there was also no significant change in results (not presented here).
Analyses comparing high and low variability groups within each mean SBP and DBP quartile showed that the development of HT was more frequent in the high variability groups than the low variability groups consistently for some of SBP variability parameters (SBP maxϪmin , SBP svmax ) and most of 
Discussion
To the best of our knowledge, this is the first study to report an association between BP variability and the development of HT after acute ischemic stroke independent of BP level and thrombolysis. BP is generally very dynamic; it fluctuates considerably during the first several hours of stroke. 22 When brain is attacked by ischemic stroke, a failure of cerebral autoregulation occurs, and blood flow is mainly determined by the systemic arterial pressure in ischemic brain regions. As a result, even minor fluctuations in BP may lead to under-or overperfusion of ischemic brain. 22, 23 Although several studies have shown that HT is associated with the absolute level of BP, an association between the development of HT and BP variability has not yet been established. 6, 24, 25 We examined various measures of BP variability, including extreme values (max and min), the maximal difference (labeled as maxϪmin), SD, and sv, and most of those variability parameters showed an independent association with the development of HT. Furthermore these findings were supported by the simple stratified analyses; when dividing patients into mean BP quartiles and further splitting the members of each quartile into high and low variability groups (Figure 1 ), 13 most variability parameters for DBP (SD, maxϪmin, sv, svmax) and some for SBP (maxϪmin, svmax)
were consistently associated with HT across all the mean BP quartiles. Recently, Yong and Kaste reported that SBP profiles, such as baseline (initial), mean, max, and sv of SBP, during the first 24 hours were independent predictors of parenchymal hemorrhage in tPA-treated patients. 15 There were some differences between our results and the results of Yong and Kaste. All the associations of SBP profiles and HT were not significant in patients not receiving thrombolysis in the study by Yong and Kaste. However, in our study, there was no interaction between most of BP parameters and thrombolysis, which means that the effects of BP profiles on HT are independent of whether patients were given thrombolysis or not. Although differences in study design and methods, such as clinical trial versus retrospective observational study, gathering SBP during the first 24 hours versus during the first 72 hours, and adjustment for mean SBP versus no adjustment, may partly explain those discrepancies, they do not seem to offer a complete explanation. Further studies are warranted.
It is noteworthy in the present study that the variability parameters for DBP were more closely related to HT than those for SBP. Previous studies about BP variability and stroke outcome have also reported that DBP variability might be more closely correlated with stroke outcome than either mean BP or SBP variability, although the reasons are not known. 13, 14 When excluding studies based on thrombolysis trials or restricting their subjects to patients receiving thrombolysis, it is not easy to find reports concerning the effects of BP parameters on the development of HT. One study reported that BP was not related to the incidence of HT in patients with acute cerebral embolism. 10 However, rather than various parameters representing the dynamics of BP, the only measure used in that study was a mean BP during hospitalization. Using a time-invariant parameter only could have led to an influence of BP on clinical outcome being missed. 14 Despite the evidence supporting the association of high BP level and poor outcome, some researchers maintain that BP is of little prognostic value. 26 Others even argue that constantly high BP can contribute to good outcome. 27 This controversy may be attributable to there being parallel harmful and beneficial effects associated with high BP. On one hand, high BP increases the risk of cerebral edema and HT in an infarcted area. On the other hand, high BP helps to preserve perfusion at an ischemic penumbra. 28 Maintaining high BP could be beneficial if perfusion of an ischemic area is inadequate because of incomplete recanalization or poor collaterals. Low BP or BP fluctuation could increase infarct size and, as a result, lead to poor outcome. 29 In contrast, if an occluded vessel is recanalized, high BP may provoke edema or HT. Under these circumstances, there is no doubt that it would be beneficial to maintain BP relatively low and constant within a reasonable range. 14 Some limitations of the present study need to be addressed. These include the study being performed in a single university hospital and the retrospective design, which meant that the modality and timing of brain images used to detect HT, as well as the frequency of BP measurements, were variable. Nevertheless, our results strongly suggest that BP variability contributes to the development of HT following acute ischemic stroke. This implies that an effort to maintain BP constantly during the acute stage of ischemic stroke may prevent HT and improve clinical outcome. However, further studies are required to confirm if BP variability does indeed cause HT and to identify the mechanism by which this might occur. Full Article
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